Dopamine and Frontostriatal Function
多巴胺和额纹状体功能
基本信息
- 批准号:9063531
- 负责人:
- 金额:$ 65.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAttention Deficit DisorderAttention deficit hyperactivity disorderBehavioralBrainBromocriptineCOMT geneClinicalCognitionCognitiveComplexCorpus striatum structureDRD2 geneDataData SetDiagnosisDiseaseDopamineDopamine D2 ReceptorDopaminergic AgentsDrug AddictionEquilibriumEtiologyEvaluationExhibitsFunctional Magnetic Resonance ImagingFunctional disorderGeneticGenetic PolymorphismGenetic VariationHealthHumanIndividualKnowledgeLeadLinkMRI ScansMaintenanceMeasurementMeasuresMental disordersMissionNatureNeurotransmittersParkinson DiseasePharmaceutical PreparationsPlacebosPositron-Emission TomographyPrefrontal CortexProcessProxyPublic HealthResearchResistanceRestRoleSchizophreniaShort-Term MemorySiteSystemTask PerformancesTestingTracerTraumatic Brain InjuryUpdateVariantaddictioncognitive controlcognitive functioncognitive processcognitive systemflexibilityimaging modalityimprovedinhibitor/antagonistinsightinterestnervous system disordernovelnovel strategiesreceptor densityrelating to nervous systemresponsetolcaponetransmission process
项目摘要
DESCRIPTION (provided by applicant): This application is directed towards understanding the role of the dopaminergic system in higher cognitive function such as working memory and cognitive control. These somewhat ill-defined terms generally refer to cognitive systems that require two functionally opposing processes: (1) the stable 'on-line' maintenance of information (necessary for "cognitive stability") and (2) the flexible updating of that information in response
to novel task-relevant information (necessary for "cognitive flexibility"). We will test the hypothesis that these cognitive processes are highly dependent on precisely balanced dopaminergic transmission within the striatum and prefrontal cortex (PFC). Specifically, we will test the hypothesis that augmentation of dopamine in the PFC promotes cognitive stability by increasing distractor-resistance whereas dopamine augmentation in the striatum promotes cognitive flexibility by allowing the updating of newly relevant representations. Manipulation of the dopaminergic system has been shown to modulate the function of fronto-striatal circuitry, but the direction and extent of these effects vary widely across individuals and tasks. Through pharmacological manipulation and genetic variation of dopamine in humans, and measurements of their effects with both fMRI and PET, we expect to elucidate the factors that determine this large variability in drug effects and characterize the nature of the complex relationship between dopamine and cognition. Dopamine is of fundamental importance to the etiology and clinical manifestations of a wide variety of neurological and psychiatric disorders such as Parkinson's disease, traumatic brain injury, attention deficit hyperactivity disorder, schizophrenia and drug addiction. A further understanding of the relationship between dopamine and cognition should advance our understanding of the mechanisms underlying cognitive and behavioral deficits in these disorders and provide insight into novel approaches to treating such deficits with medications targeted at specific neurotransmitter systems.
描述(申请人提供):本申请旨在了解多巴胺能系统在高级认知功能中的作用,如工作记忆和认知控制。这些定义有些不明确的术语通常指的是认知系统,它需要两个功能相反的过程:(1)稳定的在线信息维护(对“认知稳定性”来说是必要的)和(2)灵活地更新响应信息
与任务相关的新信息(“认知灵活性”所必需的)。我们将检验这一假设,即这些认知过程高度依赖于纹状体和前额叶皮质(PFC)内精确平衡的多巴胺能传递。具体地说,我们将测试这一假设,即PFC中的多巴胺增加通过增加分心干扰抵抗来促进认知稳定性,而纹状体中的多巴胺增加则通过允许更新新的相关表征来促进认知灵活性。对多巴胺能系统的操纵已被证明可以调节额纹状体回路的功能,但这些影响的方向和程度因个人和任务的不同而有很大差异。通过对多巴胺在人类体内的药理操作和遗传变异,以及用功能磁共振成像和正电子发射计算机断层扫描对它们的影响进行测量,我们期望阐明决定药物效应如此大的变异性的因素,并表征多巴胺和认知之间复杂关系的本质。多巴胺对帕金森氏病、创伤性脑损伤、注意力缺陷多动障碍、精神分裂症和药物成瘾等多种神经和精神疾病的病因和临床表现具有重要意义。进一步了解多巴胺和认知之间的关系将促进我们对这些疾病认知和行为缺陷的机制的理解,并为针对特定神经递质系统的药物治疗此类缺陷的新方法提供洞察力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK D'ESPOSITO其他文献
MARK D'ESPOSITO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK D'ESPOSITO', 18)}}的其他基金
Developing Behavioral and Neuroimaging Predictors of Stroke Recovery
开发中风恢复的行为和神经影像预测因子
- 批准号:
10552568 - 财政年份:2019
- 资助金额:
$ 65.78万 - 项目类别:
Neural dynamics of human working memory networks
人类工作记忆网络的神经动力学
- 批准号:
9357693 - 财政年份:2016
- 资助金额:
$ 65.78万 - 项目类别:
Neural dynamics of human working memory networks
人类工作记忆网络的神经动力学
- 批准号:
9753357 - 财政年份:2016
- 资助金额:
$ 65.78万 - 项目类别:
Neural dynamics of human working memory networks
人类工作记忆网络的神经动力学
- 批准号:
9220160 - 财政年份:2016
- 资助金额:
$ 65.78万 - 项目类别:
Neural dynamics of human working memory networks
人类工作记忆网络的神经动力学
- 批准号:
9981486 - 财政年份:2016
- 资助金额:
$ 65.78万 - 项目类别:
Investigating brain network dynamics with simultaneous TMS-fMRI
利用同步 TMS-fMRI 研究大脑网络动态
- 批准号:
8822929 - 财政年份:2014
- 资助金额:
$ 65.78万 - 项目类别:
Investigating brain network dynamics with simultaneous TMS-fMRI
利用同步 TMS-fMRI 研究大脑网络动态
- 批准号:
8685046 - 财政年份:2014
- 资助金额:
$ 65.78万 - 项目类别:
Mechanisms of Neuroplasticity in Functional Brain Networks
功能性大脑网络的神经可塑性机制
- 批准号:
8608615 - 财政年份:2013
- 资助金额:
$ 65.78万 - 项目类别:
Mechanisms of Neuroplasticity in Functional Brain Networks
功能性大脑网络的神经可塑性机制
- 批准号:
8990057 - 财政年份:2013
- 资助金额:
$ 65.78万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 65.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 65.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 65.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




